Jhaveri KL, Bellet-Ezquerra M, Turner NC, Loi S, et al. Phase Ia/b Study of Giredestrant +/-Palbociclib and +/-Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer. Clin Cancer Res 2023 Nov 3. doi: 10.1158/1078-0432.CCR-23-1796.
PMID: 37921755